Email this article to a friend
Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation
-
* Corresponding author: Marya D Zilberberg mzilberb@schoolph.umass.edu
Critical Care 2009, 13:R94 doi:10.1186/cc7924